WCRC Researched Brand · World's Most Powerful Brands 2026 · Second Global Mega Edition
Abbott
Abbott Laboratories is a US healthcare company with four segments: diagnostics, medical devices, nutrition and established pharmaceuticals. Its consumer-facing brands include the FreeStyle Libre glucose monitoring system, Similac infant formula and Ensure. In 2025 it reported sales of US$44.3bn and net earnings of US$6.5bn, and it holds AA-range credit ratings. WCRC's research found the brand strongest in financial stability and institutional confidence, in its competitive financial position, in a broad but logical four-segment portfolio, and in an innovation pipeline led by devices such as Libre and structural heart products. Its clear health-technology positioning has allowed it to extend credibly across diagnostics, devices, nutrition and generic medicines.
- Region
- Americas
- Country
- United States
- WCRC research
- Full 50-parameter assessment
What WCRC found
Strong financial stability, with AA-range credit ratings and 2025 net earnings of US$6.5bn.
Logical four-segment portfolio spanning diagnostics, medical devices, nutrition and established pharmaceuticals.
Innovation pipeline led by devices such as the FreeStyle Libre glucose monitor and structural heart products.
What holds it back: Crisis handling around infant formula holds it back: the 2022 Sturgis formula recall and ongoing NEC lawsuits over Similac remain unresolved.
Status in the 2026 edition
Abbott was assessed in full on all 50 WCRC parameters for the 2026 edition. It is not among the 100 ranked brands.
WCRC publishes scores only for the 100 ranked brands. How WCRC ranks brands.
Questions people ask
Is Abbott in the WCRC World's Most Powerful 100 Brands 2026?
Abbott was assessed in full on all 50 WCRC parameters for the 2026 edition. It is not among the 100 ranked brands.
Which Healthcare & Life Sciences brands are ranked in 2026?
No Healthcare & Life Sciences brand reached the 2026 top 100.